Photo of Chung-Che J. Chang, MD, PhD, FCAP

Chung-Che J. Chang, MD, PhD, FCAP

Pathologist

Expertise

Education

National Yan-Ming Medical College, Shipai, Beitou District, Taipei, Taiwan

Residency

Metrohealth Medical Center, Cleveland, OH

Board Certifications

American Board of Pathology

Back to Top
Publications
  • Getting Your Laboratory on Track With Neurotrophic Receptor Tyrosine Kinase
    , ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
  • Mast cell sarcoma: clinicopathologic and molecular analysis of 10 new cases and review of literature
    , MODERN PATHOLOGY
  • Clinicopathologic Features of Lymphoproliferative Neoplasms Involving the Liver
    , MEDICINA-LITHUANIA

    More sources loaded

  • Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?
    , FRONTIERS IN ONCOLOGY
  • Mutational profiling of myeloid neoplasms associated genes may aid the diagnosis of acute myeloid leukemia with myelodysplasia-related changes
    , LEUKEMIA RESEARCH
  • Adverse Overall Survival Impact of PD-L1 Positivity in Patients With KRAS G12C Mutation Is Abolished by the Immunotherapy
    , CLINICAL LUNG CANCER
  • Comparison of Myeloablative versus Reduced-Intensity Conditioning Regimens in Allogeneic Stem Cell Transplantation Recipients with Acute Myelogenous Leukemia with Measurable Residual Disease-Negative Disease at the Time of Transplantation: A Retrospective Cohort Study
    , TRANSPLANTATION AND CELLULAR THERAPY
  • Adverse Impact of DNA Methylation Regulatory Gene Mutations on the Prognosis of AML Patients in the 2017 ELN Favorable Risk Group, Particularly Those Defined by NPM1 Mutation
    , DIAGNOSTICS
  • Local ALK-Positive Histiocytosis With Unusual Morphology and Novel TRIM33-ALK Gene Fusion
    , INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
  • Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung Adenocarcinoma
    , CLINICAL LUNG CANCER
Back to Top

Associated Clinical Trials

Back to Top